Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK Regulatory System Progress And New MedTech Directorate Unveiled At Industry Meeting

More momentum behind post-EU regulatory arrangements at home and globally

Executive Summary

In the three months since Brexit, UK medtech stakeholders have seen the beginnings of new regulations, foreign trade plans being put in place, and perhaps new perceptions of medtech’s value.

You may also be interested in...



Hoping For A New Dawn In UK’s Value-Based Procurement

The UK’s MedTech Directorate is undergoing a partial relaunch, with a new director set to take the reins and a new strategy being finalized. The medtech industry hopes the renewed impetus will put long-overdue attention to value-based procurement for medtech goods.

Startup Spotlight: INBRAIN Hopes To Leapfrog Brain Electrode Competition

By utilizing the properties of graphene, INBRAIN hopes to develop improved electrodes implanted in the brain, raising the potential of neuromodulation for treating complex neurological disorders.

UK Medicines And Medical Devices Act 2021 Passed Into Law

The duties of the new commissioner for patient safety have been prioritized in the UK’s Medicines and Medical Devices bill, which has been given Royal Assent.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT143748

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel